Table 4.
UACR | rGFR | |||
---|---|---|---|---|
Standard β | P | Standard β | P | |
Model 1 | ||||
FABP4 | 0.124 | 0.109 | −0.364 | <0.0001 |
NGAL/Cr | 0.110 | 0.137 | −0.200 | 0.006 |
CysC/Cr | 0.307 | <0.0001 | −0.091 | 0.235 |
RBP4 | 0.440 | <0.0001 | −0.163 | 0.034 |
UACR | −0.250 | <0.0001 | ||
Model 2 | ||||
FABP4 | 0.107 | 0.289 | −0.349 | <0.0001 |
NGAL/Cr | 0.065 | 0.455 | −0.095 | 0.220 |
CysC/Cr | 0.295 | 0.001 | −0.077 | 0.331 |
RBP4 | 0.441 | <0.0001 | −0.159 | 0.045 |
UACR | −0.232 | 0.001 | ||
Model 3 | ||||
FABP4 | 0.063 | 0.488 | −0.367 | <0.0001 |
NGAL/Cr | 0.082 | 0.343 | −0.052 | 0.554 |
CysC/Cr | 0.450 | <0.0001 | −0.046 | 0.652 |
RBP4 | 0.519 | <0.0001 | −0.114 | 0.250 |
UACR | −0.118 | 0.235 |
Model 1: crude model without covariate adjustment; model 2: adjustment for age, sex, BMI, waist circumference, SBP, HbA1c, and use of ACEI/ARBs; model 3: adjustment for age, sex, BMI, WC, SBP, use of ACEI/ARBs, and all the other potential damage biomarkers in the table. UACR, urinary albumin-to-creatinine ratio; rGFR, radioisotope glomerular filtration rate; FABP4, fatty acid-binding protein 4; NGAL/Cr, neutrophil gelatinase associated lipocalin-to-creatinine ratio; Cys-C/Cr, cystatin C-to-creatinine ratio; RBP4, retinal-binding protein 4.